Nearly three decades after the murder of six-year-old JonBenét Ramsey shocked Colorado and drew national attention, her ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

Jeffrey V. Ravetch (left) and Andrew T. Jones (right) showed that the anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II ...

Hansa Biopharma AB, ("Hansa" or "the Company"), (Nasdaq Stockholm: HNSA), today announced the submission of a Biologics License ...

Investigators evaluated whether the addition of carboplatin to neoadjuvant chemotherapy improved efficacy outcomes in patients with early-stage TNBC.

Nearly three decades after the 1996 murder of 6-year-old JonBenét Ramsey in Boulder, Colorado, her father, John Ramsey, says ...

Enrollment in the SAFEGUARD trial is ongoing at multiple centers globallyCompany on-track to share Phase 2b data in 2H 2027 ...

Hansa Biopharma AB ( ($SE:HNSA) ) has issued an update. Hansa Biopharma AB announced that CEO Renée Aguiar-Lucander will present at J.P. Morgan’s ...

Kenneth Smith posthumously linked to murders of three women in 1980s and ’90s, police say there may have been more victims ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types ...

Relation's draw is its 'lab-in-a-loop' process of AI-driven target and drug discovery, in which algorithms are used to find ...